CompletedPhase 2NCT03827018
KPL-301 for Subjects With Giant Cell Arteritis
Studying Giant cell arteritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kiniksa Pharmaceuticals, Ltd.
- Principal Investigator
- John Paolini, M.D.Kiniksa Pharmaceuticals, Ltd.
- Intervention
- mavrilimumab(combination_product)
- Enrollment
- 70 target
- Eligibility
- 50-85 years · All sexes
- Timeline
- 2018 – 2020
Study locations (30)
- Site 1703, Sarasota, Florida, United States
- Site 1708, Tampa, Florida, United States
- Site 1706, Atlanta, Georgia, United States
- Site 1701, Boston, Massachusetts, United States
- Site 1707, Lansing, Michigan, United States
- Site 1704, Saint Clair Shores, Michigan, United States
- Site 1702, Rochester, Minnesota, United States
- Site 1705, New York, New York, United States
- Site 2102, Kogarah, Australia
- Site 2105, Nedlands, Australia
- Site 2106, Parkville, Australia
- Site 2101, Victoria Park, Australia
- Site 2104, Woodville South, Australia
- Site 2204, Brussels, Belgium
- Site 2202, Leuven, Belgium
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03827018 on ClinicalTrials.govOther trials for Giant cell arteritis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07108387Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell ArteritisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNCT07084480Giant Cell Arteritis - Ways to Precision MedicineWuerzburg University Hospital
- RECRUITINGNANCT07001059oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSoundHôpital NOVO
- RECRUITINGNCT06894602Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell ArteritisUniversity Hospital, Brest
- RECRUITINGNCT05749094Optic Nerve Sheath Ultrasound in Giant Cell ArteritisCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- ACTIVE NOT RECRUITINGNCT05703763The Applanation Tonometry in GCA PilotCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- RECRUITINGPHASE2NCT06887062Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)University of Edinburgh
- RECRUITINGNCT06742671Performance of a Fast-track Pathway for Giant Cell Arteritis DiagnosisGroupe Hospitalier de la Rochelle Ré Aunis